PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
21.98%
Revenue growth above 1.5x TSM's 14.32%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
25.31%
Gross profit growth above 1.5x TSM's 16.62%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
30.69%
EBIT growth above 1.5x TSM's 18.00%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
30.69%
Operating income growth above 1.5x TSM's 18.00%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
32.91%
Net income growth above 1.5x TSM's 15.19%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
31.58%
EPS growth above 1.5x TSM's 15.14%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
32.43%
Diluted EPS growth above 1.5x TSM's 15.23%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.08%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.16%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
2.14%
Dividend growth under 50% of TSM's 14.29%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
56.83%
OCF growth 1.25-1.5x TSM's 50.37%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
59.41%
FCF growth above 1.5x TSM's 30.80%. David Dodd would verify if the firm’s strategic investments yield superior returns.
1681.26%
10Y revenue/share CAGR above 1.5x TSM's 290.28%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
890.21%
5Y revenue/share CAGR above 1.5x TSM's 173.78%. David Dodd would look for consistent product or market expansions fueling outperformance.
343.59%
3Y revenue/share CAGR above 1.5x TSM's 98.18%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
2546.14%
10Y OCF/share CAGR above 1.5x TSM's 303.63%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
1164.93%
5Y OCF/share CAGR above 1.5x TSM's 205.62%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
458.57%
3Y OCF/share CAGR above 1.5x TSM's 64.01%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
7610.59%
Net income/share CAGR above 1.5x TSM's 432.31% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
2040.31%
5Y net income/share CAGR above 1.5x TSM's 222.93%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
746.59%
3Y net income/share CAGR above 1.5x TSM's 131.24%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
789.30%
10Y equity/share CAGR above 1.5x TSM's 319.56%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
354.45%
5Y equity/share CAGR above 1.5x TSM's 165.78%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
155.44%
3Y equity/share CAGR above 1.5x TSM's 97.81%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
88.89%
Below 50% of TSM's 211716793.20%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
-0.21%
Negative 5Y dividend/share CAGR while TSM stands at 100.04%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
0.41%
Below 50% of TSM's 45.49%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
20.34%
AR growth well above TSM's 8.85%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.53%
We show growth while TSM is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
21.39%
Asset growth above 1.5x TSM's 8.54%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
29.30%
BV/share growth above 1.5x TSM's 7.50%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.26%
Debt shrinking faster vs. TSM's 8.57%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
7.45%
R&D growth drastically higher vs. TSM's 8.43%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3.34%
SG&A declining or stable vs. TSM's 10.70%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.